Clinical Trials on Acute Alcoholic Hepatitis in Switzerland

Total 404 results

Gilead Sciences

Completed

Selonsertib in Combination With Prednisolone Versus Prednisolone Alone in Participants With Severe Alcoholic Hepatitis (AH)

Alcoholic Hepatitis (AH)

Austria, United Kingdom, France, United States, Canada, Belgium, Switzerland
University Hospital, Geneva

Completed

Emergency Department (ED) Triage of Alcohol Abuse

Alcoholic Intoxication

Switzerland
University of Zurich
Schweizerischer Nationalfonds

Completed

Clinical and Mechanistic Effects of Psilocybin in Alcohol Addicted Patients

Alcohol Use Disorder

Switzerland
University of Bern
Clinic Suedhang

Recruiting

Brain Connectivity Between Networks Implied in Inhibition and Cue-reactivity in Alcohol Use Disorder (NIQA)

Alcohol Use Disorder

Switzerland
Prof. Daniele Zullino

Completed

Nalmefene, Baclofen and Impulsivity in Subjects With Alcohol Use Disorder and Healthy Control Subjects

Alcohol Use Disorder

Switzerland
Felix Mueller
University of Bern

Not yet recruiting

LSD Treatment for Persons With Alcohol Use Disorder (LYSTA)

Alcohol Use Disorder (AUD)

Switzerland
University of Bern
Forel Clinic; Clinic Südhang; Psychiatric Center Muensingen

Completed

Learning to Resist the Urge: Inhibition Training in Abstinent Patients With Alcohol Use Disorders (INTRA)

Alcohol Dependence

Switzerland
Susanne Rösner
New York University; University of Hamburg-Eppendorf; University of Konstanz; Zurich...

Completed

Mental Contrasting With Implementation Intentions for Alcohol Use Disorders (MCIIAUD)

Alcohol Use Disorder

Switzerland
University of Bern

Completed

Telephone-Based Continuing Care for Alcohol Dependence

Alcohol Dependence

Switzerland
University of Lausanne Hospitals

Completed

Indocyanine Green and Portal Pressure in Viral and Alcoholic Cirrhotic Patients With Hepatocarcinoma

Carcinoma, Hepatocellular | Alcoholic Cirrhosis | Viral Cirrhosis | Postoperative Hepatic Failure

Switzerland
University Hospital Inselspital, Berne

Completed

Acute Effects of Cortisol on Alcohol Craving in Alcohol Dependence (CAR-Bern 2013)

Psychological Stress | Physiological Stress | Alcohol Craving

Switzerland
University Hospital, Basel, Switzerland

Completed

Glucose-induced Glucagon-like Peptide 1 (GLP-1) Secretion in NAFLD Patients Compared to Healthy Controls

Non Alcoholic Fatty Liver Disease | Non Alcoholic Steatohepatitis

Switzerland
Pevion Biotech Ltd

Completed

Phase I Hepatitis C Vaccine Trial of Virosome-formulated Peptides

Chronic Hepatitis C

Switzerland
Bristol-Myers Squibb
Basel Institute of Clinical Epidemiology (BICE)

Completed

Effectiveness Of Daclatasvir-Based Regimens In Patients With Chronic Hepatitis C Infection In Europe: Experience From Named Patient Program And From Early Post-Marketing Authorization Period

Hepatitis C

Switzerland
University Hospital, Basel, Switzerland

Terminated

Telbivudine Versus Lamivudine for Maintenance Therapy of Patients With Chronic Hepatitis B and Negative HBV Viral Load After 6 Month of Treatment With Telbivudine (SASL28)

Hepatitis, Chronic

Switzerland
University Hospital, Basel, Switzerland

Completed

Chronic Hepatitis C Non-Responder Study With AdoMet and Betaine

Hepatitis C

Switzerland
University Hospital, Geneva

Completed

Retreatment of Chronic Hepatitis C Non-responders With Pegylated Interferon Alpha Plus Ribavirin Plus Pioglitazone

Chronic Hepatitis C

Switzerland
Ente Ospedaliero Cantonale, Bellinzona
Clinical Trial Unit Ente Ospedaliero Cantonale; Swiss Transfusion SRC

Completed

Seroprevalence Hepatitis E Infection in Healthy Blood Donors

Hepatitis E

Switzerland
University of Zurich
PD Dr. rer. nat. Mathias Heikenwälder

Unknown

A Phase 1b, Single Center, Clinical Study to Investigate the Safety and Biological Responses to Baminercept in Patients With Chronic HCV Hepatitis.

Chronic HCV Hepatitis C

Switzerland
Kantonsspital Olten

Completed

Pulmonary Arterial Hypertension in Patients With Direct-Acting Antiviral Medications for Hepatitis C Virus Infection

Pulmonary Artery Hypertension | Chronic Hepatitis c

Switzerland
University of Zurich

Completed

Treatment of Non-alcoholic Steatohepatitis (NASH) Patients With Vitamin D

Non-alcoholic Steatohepatitis (NASH)

Switzerland
University Hospital, Geneva
Gastaldi Giacomo; Clément Sophie

Completed

Extrahepatic Insulin Resistance in Chronic Hepatitis C

Insulin Resistance

Switzerland
University of Bern
Roche Pharma AG; University of Lausanne; University of Basel; Cantonal Hospital... and other collaborators

Completed

High Dose Ribavirin in the Treatment of Chronic Hepatitis C

Chronic Hepatitis C

Switzerland
University of Lausanne Hospitals

Completed

What is the Anti-HAV Seroprevalence of Travelers >60 Years or Having Lived in a Tropical Country for >5 Years (AHAV)

Hepatitis A

Switzerland
University of Zurich

Completed

Swiss HCVree Trial (HCVree)

Hepatitis C | HIV

Switzerland
University of Zurich

Completed

THISTLE - The HIV-HCV Silibinin Trial (THISTLE)

Hepatitis C | HIV

Switzerland
University Hospital, Geneva

Completed

Dietary Intervention and Intestinal Microbiota in Non-alcoholic Fatty Liver

Obesity | Non-alcoholic Fatty Liver Disease (NAFLD)

Switzerland
University of Oxford
GlaxoSmithKline; Cantonal Hospital of St. Gallen; St. James's Hospital, Ireland; ReiThera Srl

Completed

A Study to Assess the Safety of Hep C Vaccine Candidates in HIV Seropositive Individuals

Hepatitis C Infection

Switzerland, Ireland
AbbVie

Completed

Quality of Life Measurement in Treatment Naïve Patients With Hepatitis C Virus (HCV) Genotype 1 (GT1) Suffering From Fatigue and Receiving Ombitasvir, Paritaprevir, and Ritonavir and Dasabuvir (Viekirax®/Exviera®) (HEMATITE)

Chronic Hepatitis C Virus (HCV)

Switzerland
University Hospital, Basel, Switzerland
Kantonsspital St. Gallen, St. Gallen, Switzerland

Recruiting

Seroprevalence of Leptospirosis in Val Müstair, Switzerland

Leptospirosis | Tularemia | Hepatitis E Virus Infection

Switzerland
Yaqrit Ltd
Assistance Publique - Hôpitaux de Paris; IRCCS Azienda Ospedaliero-Universitaria... and other collaborators

Withdrawn

Safety and Tolerability of Yaq-001 in Patients With Non-Alcoholic Steatohepatitis

Non-Alcoholic Steatohepatitis

France, Italy, Portugal, Spain, Switzerland, United Kingdom
GlaxoSmithKline

Completed

Evaluate Immune Response Approximately 5 to 6 Years After Receiving Different Formulations of GSK Bio Hep B Vaccine

Hepatitis B

Belgium, Germany, Switzerland
Fondazione Epatocentro Ticino

Recruiting

Swiss Autoimmune Hepatitis Cohort Study

Hepatitis, Autoimmune

Switzerland
University of Zurich

Recruiting

Prospective Cohort Study in Patients With NAFLD

Non-alcoholic Fatty Liver Disease

Switzerland
Novartis Pharmaceuticals

Terminated

Liver Fibrosis in Patients Transplanted for Hepatitis C Receiving Either Cyclosporine Microemulsion or Tacrolimus

Hepatitis C | Liver Transplant

United States, Switzerland
University Hospital, Basel, Switzerland

Completed

Smoking Cessation in Alcoholics

Smoking Cessation | Alcohol Consumption

Switzerland
Cytheris SA

Unknown

Dose Escalation Study of Interleukin-7 (IL-7) and Bitherapy in HCV Genotype 1 or 4 Patients Resistant to Bitherapy Alone (Eclipse 2)

Hepatitis C

France, Switzerland, Italy
University Hospital, Basel, Switzerland

Completed

Magnetic Resonance Imaging (MRI) Fat Quantification of the Liver

Obesity | Non-alcoholic Fatty Liver Disease

Switzerland
Cytheris SA

Completed

Dose Escalation Study of IL-7 and Bi-therapy in HCV Patients Resistant After 12 Weeks of Bi-therapy (ECLIPSE 1) (ECLIPSE 1)

Hepatitis C

France, Switzerland, Italy
Gilead Sciences

Completed

Sofosbuvir/Velpatasvir Fixed Dose Combination in Participants With Chronic Hepatitis C Virus Infection Who Have Received a Liver Transplant

Hepatitis C Virus Infection

Spain, Switzerland, United Kingdom
National Cancer Institute (NCI)

Completed

Raltitrexed in Treating Children With Refractory Acute Leukemia

Recurrent Childhood Acute Lymphoblastic Leukemia | Recurrent Childhood Acute Myeloid Leukemia

Switzerland
University of Lausanne

Completed

A Pilot Study on Whey Protein Supplementation in Non Alcoholic Fatty Liver Disease (PROTOB)

Obesity | Non-alcoholic Fatty Liver Disease

Switzerland
Janssen Pharmaceutica N.V., Belgium

Completed

Telaprevir With Peginterferon Alfa & Ribavirin in Ex-People Who INject Drugs Infected by Genotype 1 Chronic Hepatitis C (INTEGRATE)

Hepatitis, Chronic

France, United Kingdom, Belgium, Germany, Netherlands, Switzerland
Prof. Dagmar M. Haller

Not yet recruiting

Substance Use Screening to Encourage Behavior Change Among Young People in Primary Care (YP-HEALTH)

Binge Drinking | Substance Use | Cannabis Use | Adolescent Behavior

Switzerland
University of Zurich
Balgrist University Hospital

Completed

Developing an Objective Measure of Experienced Pain

Pain, Acute

Switzerland
University Hospital, Geneva

Completed

Swiss PACK-CXL Multicenter Trial for the Treatment of Infectious Keratitis

Keratitis; Infectious Disease (Manifestation)

Switzerland
University of Zurich

Completed

Development and Validation of an Enhanced Prediction Score for Postoperative Acute Renal Failure After Liver Resection

Acute Renal Failure

Switzerland
GlaxoSmithKline

Completed

Safety and Immunogenicity of 3 Lots of GSK Biologicals' HBV-MPL Vaccine and Engerix™-B in Healthy Volunteers ≥ 15y

Hepatitis B

Australia, Czech Republic, Germany, Italy, Netherlands, Switzerland, United Kingdom
University Hospital, Geneva

Completed

Pain Evaluation and Treatment in the Emergency Department

Emergencies | Pain, Acute

Switzerland
University of Zurich

Completed

Novel Prediction Score for Postoperative Acute Renal Failure (ARF) Following Liver Resection (StV 11-2008)

Acute Renal Failure

Switzerland

Clinical Trials on Acute Alcoholic Hepatitis in Switzerland

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Dominican Republic

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations